Third-party tested — Certificate of Analysis on every batch
V8 Peptides — Engineered Performance
Research Library
CJC-1295 (No DAC): Research FAQ
CJC-1295 No DACFAQ

CJC-1295 (No DAC): Research FAQ

V8 Peptides Research TeamAugust 15, 2026

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Common questions researchers ask about CJC-1295 (no DAC) — laboratory context only.

What does "no DAC" mean?

It refers to the absence of the Drug Affinity Complex modification used in the longer-acting CJC-1295 (DAC) variant. The no-DAC form is the modified-GHRH-fragment backbone alone, without the albumin-binding moiety, giving it a materially shorter research half-life — a distinction explained in its mechanism of action.

Is no-DAC CJC-1295 the same as Mod GRF (1-29)?

The two names are frequently used for functionally similar modified-GHRH-fragment peptides in the literature; the shared structural logic (stabilizing substitutions on the same 29-residue GHRH fragment used in sermorelin) is covered in the chemistry article.

Why pair it with ipamorelin in research?

The GHRH-mimetic and ghrelin-mimetic pathways converge on GH release; see the paired-secretagogue research article.

How is it supplied and handled?

Lyophilized powder, kept cold and dark; general handling is in reconstitution and storage.

What documentation should accompany a lot?

A lot-specific certificate of analysis with HPLC purity and mass-spec identity — see how to read a CoA.

Product page: CJC-1295 (No DAC) research vials.

Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.